Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07815951
What this trial is testing

Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors

Who this might be right for
Solid TumorsCarcinomaOvarian Neoplasms+4 more
Yong He 8
Testing effectiveness (Phase 2)UnknownNCT05515783
What this trial is testing

68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies

Who this might be right for
Tumor
First Affiliated Hospital of Fujian Medical University 50
Not applicableNot Yet RecruitingNCT05263466
What this trial is testing

Establishing Radiolabelled PSMA as a Target for Glioma Treatment

Who this might be right for
Glioma, Malignant
King's College Hospital NHS Trust 30
Not applicableWithdrawnNCT04176900
What this trial is testing

3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study

Who this might be right for
Skin Neoplasm MalignantSkin Cancer
Nova Scotia Cancer Centre
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765940
What this trial is testing

Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer

Who this might be right for
Prostate Cancer
RadAlliance Therapeutics, Inc 52
Testing effectiveness (Phase 2)Looking for participantsNCT04917484
What this trial is testing

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients

Who this might be right for
Neuroendocrine Neoplasm
Tine Gregersen, MD 100
Early research (Phase 1)Looking for participantsNCT07801508
What this trial is testing

[68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

Who this might be right for
Advanced Gastroesophageal AdenocarcinomaAdvanced Breast CancerTriple-negative Breast Cancer+1 more
Novartis Pharmaceuticals 66
Early research (Phase 1)Study completedNCT05989997
What this trial is testing

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Who this might be right for
Solid TumorPositron-Emission Tomography(PET)
SmartNuclide Biopharma 17
Early research (Phase 1)Study completedNCT03995888
What this trial is testing

Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer

Who this might be right for
Prostate Cancer
Blue Earth Diagnostics 24
Early research (Phase 1)Study completedNCT05136391
What this trial is testing

A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers

Who this might be right for
Coronary Artery Disease (CAD)
Sinotau Pharmaceutical Group 10
Not applicableUnknownNCT05775068
What this trial is testing

ARtificial Intelligence for Gross Tumour vOlume Segmentation

Who this might be right for
Lung Cancer
Maastricht Radiation Oncology 2,000
Early research (Phase 1)Ended earlyNCT00041691
What this trial is testing

Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After Surgery

Who this might be right for
Colorectal Neoplasms
Gilead Sciences 30
Not applicableStudy completedNCT03772210
What this trial is testing

Mechanism and Dosimetry Exploration in TES Magnetic Resonance Current Mapping Methods

Who this might be right for
Transcranial Direct Current Stimulation
Arizona State University 123
Testing effectiveness (Phase 2)WithdrawnNCT03923257
What this trial is testing

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Who this might be right for
Neuroendocrine TumorsPheochromocytomaParaganglioma
Sue O'Dorisio
Testing effectiveness (Phase 2)Ended earlyNCT02592707
What this trial is testing

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Who this might be right for
Neuroendocrine Tumors
Ipsen 40
Not applicableStudy completedNCT04246125
What this trial is testing

Patient Skin Dose in Interventional Radiology

Who this might be right for
AneurysmArteriovenous MalformationsCoronary Occlusion+2 more
Assistance Publique - Hôpitaux de Paris 87
Not applicableStudy completedNCT04318340
What this trial is testing

A Novel Tapered Applicator for Vaginal Vault Brachytherapy

Who this might be right for
Endometrial CancerBrachytherapyQuality of Life
Yale University 21
Very early researchNot Yet RecruitingNCT07671417
What this trial is testing

Imaging Study in Metastatic Clear Cell RCC.

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
RayzeBio, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Not applicableEnded earlyNCT04801472
What this trial is testing

Optimisation of Potential Dental Implant Sites Protection for Rehabilitation in Patients With Head and Neck Cancer: Impact of Virtual Implants Visualisation on Dosimetry (OPPIDOM)

Who this might be right for
Squamous Cell Carcinoma of Head and NeckOropharyngeal Squamous Cell CarcinomaOral Cavity Squamous Cell Carcinoma
Institut de cancérologie Strasbourg Europe 8
Next Page